INS and congenital isolated hyperinsulinism: Moreover, CRN02481 significantly decreased insulin secretion in human islets isolated from two patients with CHI and one patient with Beckwith-Weideman Syndrome (BWS) CHI, providing ex-vivo demonstration of efficacy in targeted hyperinsulinaemic patients (63).